This document contains a survey given to 50 community pharmacists in Makati City about their knowledge, views, and preferences regarding generic medicines. The survey includes 17 statements about generic medicines that respondents identified as true/false and 5 questions about their views on a scale from strongly agree to strongly disagree. It also asks them to identify influencing factors on their views on generic medicines.
This document contains a survey given to 50 community pharmacists in Makati City about their knowledge, views, and preferences regarding generic medicines. The survey includes 17 statements about generic medicines that respondents identified as true/false and 5 questions about their views on a scale from strongly agree to strongly disagree. It also asks them to identify influencing factors on their views on generic medicines.
This document contains a survey given to 50 community pharmacists in Makati City about their knowledge, views, and preferences regarding generic medicines. The survey includes 17 statements about generic medicines that respondents identified as true/false and 5 questions about their views on a scale from strongly agree to strongly disagree. It also asks them to identify influencing factors on their views on generic medicines.
For generic drug to be bioequivalent to its innovator 23 4 23
259 Sen Gil Puyat, Makati, 1203 Metro Manila brand or other generics, the 90% confidence intervals for (+63)2 8843-0300 loc. 102 the ratio of each pharmacokinetics parameters (i.e. Cmax and AUC), must lie within the range of 90–110%. 11. A generic medicine is usually manufactured 41 0 9 without a license from the innovator company, but Views, Knowledge, and Preferences of Community Pharmacists marketed after expiry of patent or other exclusivity in Makati City Regarding Generic Medicines: A Cross-Sectional Survey rights. (Adapted questionnaire used in an article entitled 12. When two pharmaceutical products are 19 5 26 Knowledge, Attitudes and Practices of Community Pharmacists bioequivalent, it means that the Cmax and AUC ratios on Generic Medicines in Palestine: A Cross-Sectional Study by Jarrar et al.) estimated for each formulation can vary by −20 to +25%. 13. Generic medicine is inferior quality to branded 14 36 0 branded medicine. TALLY SHEET (50 RESPONDENTS) 14. Generic medicines are less expensive compared to 50 0 0 branded medicines. Knowledge of Respondents on Generic Medicines 15. Where there is a generic substitution policy (The 41 0 9 Read the statements carefully and identify whether they are True or False. Generics Act of 1988 and Universally Accessible and Put a check “√” in the appropriate box. Affordable Quality Medicines Act of 2008), the community pharmacists are allowed to dispense a TRUE FALS I DON’T different brand of the drug, but may or may not refer E KNOW back to the prescriber depending on the jurisdiction/law. 1. The term generic medicine is a drug product marketed 16. If a generic medicine is bioequivalent to a branded 50 0 0 50 0 0 medicine, it means that it is also therapeutically under the drugs non-proprietary approved name or a product marketed under a different brand name equivalent. (proprietary) name. 2. A generic medicine must be the same in dosage form 50 0 0 (e.g. tablet, capsule, syrup…etc.) as the branded Views of Respondents on Generic Medicines medicine. Put a check “√” in the appropriate box that suites your opinion. 3. A generic medicine must contain the same 50 0 0 dose/strength as the branded medicine. Strongly Agree Neutral Disagree Strongly 4. A generic medicine must contain the same active agree disagree 50 0 0 1. I support generic substitution for ingredient as the branded medicine. 5 45 0 0 0 5. Generic medicines have the same safety and effectivity brand name drugs in all cases where 32 14 4 a generic is available. property as the branded medicines. 6. Generic medicines have the same quality as the 2. I find it easier to recall a 37 4 9 0 0 5 26 19 medicine’s therapeutic class using branded medicines. 7. Generic products must be bioequivalent to the generic names rather than brand 44 0 6 names. innovator brand before they can be approved to be marketed in many developed and some developing 3. Wider use of generic medicines 5 36 9 0 0 countries. will mean that less money will be 8. Product quality data are NOT required before a generic spent for research and development 5 39 6 of new pharmaceuticals. product can be registered in such countries that require bioequivalent data. 4. I believe that generic medicines 28 22 0 0 0 9. Provided that a generic product conforms to are as safe, effective and of quality 50 0 0 as the branded medicines. bioequivalence and product quality requirements, it is assumed that its efficacy, quality and safety are similar to 5. Wider use of generic medicines 17 33 0 0 0 the original branded product. will result in decrease in health care Views, Knowledge, and Preferences of Community Pharmacists in Makati City Regarding Generic Medicines; A Cross-Sectional Survey Doctor of Pharmacy 2018-2020 expenditure by the government of prescribing physician when Philippines. substituting certain categories of 6. I prefer dispensing generic 35 9 6 0 0 drugs, such as those with narrow medicines because it costs lesser therapeutic index. than the branded medicines. 17. In general, I would not dispense 0 0 0 39 11 7. Switching a patient from 21 0 0 18 11 generic medicine to my patients. branded medicine to a generic medicine may change the outcome Influencing Factors that affects the Respondent’s Views on Generic Medicines of the drug therapy. Check “√” all that apply. 8. Therapeutic failure is a serious 9 12 0 24 5 problem with most generic Factors: Important Neutral Unimportant products. Influencing Influencing 9. All products approved as generic 19 31 0 0 0 Reputation of the manufacturer (recall 41 9 0 drugs by the health authorities in record) the Philippines can be considered Consumer’s Experiences 24 26 0 therapeutically equivalent to their Frequency of Product complaint branded counterparts. 44 6 0 10. The price difference between Professional Judgement 5 45 0 5 45 0 0 0 generic and branded drugs is often Problem reports in media/journals 46 4 0 so great that I feel I must dispense Information available on brand 38 12 0 prescriptions with generic substitution substitution. Personal Experience 23 27 0 11. Patients should be given enough 15 35 0 0 0 Appearance of the product and packaging 33 17 0 explanations about the reasons for choosing generic medicines for them. Influencing Factors that affects the Respondent’s Preferences in Dispensing 12. Community pharmacists must Generic Medicines 50 0 0 0 0 apply the policies stated in The Check “√” all that apply. Generics Act of 1988 and Universally Accessible and Factors: Important Neutral Unimportant Affordable Quality Medicines Act of influencing influencing 2008) Cost to the costumer 50 0 0 13. The intensity of promotional 26 24 0 0 0 Having no other choice 50 0 0 activities by medical Consumer preference/demand 50 0 0 representatives plays an important Availability of stock 50 0 0 role in dispensing generics. Costumer’s appearance 9 23 18 Costumer’s preference/demand 50 0 0 14. Community pharmacists should 5 30 15 0 0 be allowed to perform generic Cost-effectiveness of generic medicines 42 8 0 substitution without consulting the Proven bioequivalence to original brand 33 17 0 prescribing physician. medicines 15. Community pharmacists must 0 4 23 18 5 Personal faith on the product 41 9 0 consult the prescribing physician Substitution agreement with the prescriber 33 17 0 when performing generic Data or information about proven 41 9 0 substitution. bioequivalence to the branded medicine 16. Community pharmacists should 19 31 0 0 0 Availability of policies, laws and regulations 41 9 0 only be required to consult the
Views, Knowledge, and Preferences of Community Pharmacists
in Makati City Regarding Generic Medicines; A Cross-Sectional Survey Doctor of Pharmacy 2018-2020
Isolation of Solasodine From The Unripe Fruits of Solanum Xanthocarpum Schrad and Wendl. (Solanaceae) and It's Anti Cancer Activity Against HeLa and U937 Cell Lines PDF